The New England journal of medicine, 2019-02, Vol.380 (8), p.720-728
- Khorana, Alok A
- Soff, Gerald A
- Kakkar, Ajay K
- Vadhan-Raj, Saroj
- Riess, Hanno
- Wun, Ted
- Streiff, Michael B
- Garcia, David A
- Liebman, Howard A
- Belani, Chandra P
- O’Reilly, Eileen M
- Patel, Jai N
- Yimer, Habte A
- Wildgoose, Peter
- Burton, Paul
- Vijapurkar, Ujjwala
- Kaul, Simrati
- Eikelboom, John
- McBane, Robert
- Bauer, Kenneth A
- Kuderer, Nicole M
- Lyman, Gary H
2019
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Khorana, Alok A
- Soff, Gerald A
- Kakkar, Ajay K
- Vadhan-Raj, Saroj
- Riess, Hanno
- Wun, Ted
- Streiff, Michael B
- Garcia, David A
- Liebman, Howard A
- Belani, Chandra P
- O’Reilly, Eileen M
- Patel, Jai N
- Yimer, Habte A
- Wildgoose, Peter
- Burton, Paul
- Vijapurkar, Ujjwala
- Kaul, Simrati
- Eikelboom, John
- McBane, Robert
- Bauer, Kenneth A
- Kuderer, Nicole M
- Lyman, Gary H
- Titel
- Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
- Ist Teil von
- The New England journal of medicine, 2019-02, Vol.380 (8), p.720-728
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2019
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- A placebo-controlled trial assessed the efficacy of rivaroxaban to prevent venous thrombosis in patients with cancer at high risk for thrombosis. The thrombosis rate was lower with rivaroxaban, but for the 180-day assessment period, the difference was not significant. Bleeding was approximately twice as common in the rivaroxaban group.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa1814630Titel-ID: cdi_proquest_journals_2184231386
- Format
- –
- Schlagworte
- Administration, Oral, Adult, Aged, Aged, 80 and over, Antineoplastic Agents - therapeutic use, Bleeding, Cancer, Disease prevention, Double-Blind Method, Embolism, Factor Xa Inhibitors - adverse effects, Factor Xa Inhibitors - therapeutic use, Female, Health risk assessment, Hemorrhage - chemically induced, Humans, Incidence, Intention to Treat Analysis, Intervention, Kaplan-Meier Estimate, Lymphoma, Male, Middle Aged, Neoplasms - complications, Neoplasms - drug therapy, Oncology, Patients, Risk Factors, Rivaroxaban - adverse effects, Rivaroxaban - therapeutic use, Statistical analysis, Thromboembolism, Thrombosis, Treatment Outcome, Ultrasonic imaging, Veins & arteries, Venous Thromboembolism - etiology, Venous Thromboembolism - prevention & control